04/22/2024
3:06 PM | Astria Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:08 PM | Astria Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:10 PM | Astria Therapeutics (Filer)
| Form ARS | |
04/09/2024
7:07 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:09 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
7:11 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:37 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/11/2024
7:19 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024
11:29 AM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:48 PM | Astria Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:36 AM | Astria Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
7:59 AM | Astria Therapeutics (Filer)
| Form 424B5 | |
01/31/2024
8:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:03 PM | Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:01 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:26 PM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:39 PM | Astria Therapeutics (Subject)
Morabito Christopher (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
7:30 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:16 PM | Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
01/01/2024
11:15 PM | Astria Therapeutics (Filer)
| Form EFFECT | |
12/28/2023
1:09 PM | Astria Therapeutics (Filer)
| Form S-3/A | |
12/22/2023
1:51 PM | Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:30 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
7:30 AM | Astria Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2023
7:06 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
3:11 PM | Astria Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/18/2023
3:11 PM | Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:01 PM | Astria Therapeutics (Filer)
| Form 424B5 | |
10/12/2023
4:04 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
6:24 PM | Astria Therapeutics (Subject)
| Form FWP | |
10/11/2023
4:14 PM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:00 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:00 AM | Astria Therapeutics (Issuer)
BATE KENNETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:02 AM | Astria Therapeutics (Issuer)
Beck Joanne T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:03 AM | Astria Therapeutics (Issuer)
Clauser Noah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:04 AM | Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:04 AM | Astria Therapeutics (Issuer)
Callori Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:05 AM | Astria Therapeutics (Issuer)
Cole Hugh M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:06 AM | Astria Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/06/2023
7:06 AM | Astria Therapeutics (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:06 AM | Astria Therapeutics (Issuer)
KISHBAUCH MICHAEL D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:07 AM | Astria Therapeutics (Issuer)
Harshbarger Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:07 AM | Astria Therapeutics (Issuer)
Komjathy Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:08 AM | Astria Therapeutics (Issuer)
Matthews Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
7:08 AM | Astria Therapeutics (Issuer)
Milne Jill C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
11:15 PM | Astria Therapeutics (Filer)
| Form EFFECT | |
